These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 11366807)
1. HIV pediatric drug chart. Vazquez E Posit Aware; 1999; 10(4):48-50. PubMed ID: 11366807 [TBL] [Abstract][Full Text] [Related]
2. Kaletra lower-strength pediatric tablet approved in Europe. AIDS Patient Care STDS; 2008 May; 22(5):437-8. PubMed ID: 18521973 [No Abstract] [Full Text] [Related]
3. Children on losing end of access to new drugs. AIDS Alert; 1998 Jan; 13(1):10-2. PubMed ID: 11364862 [TBL] [Abstract][Full Text] [Related]
4. Retrovir efficacy supplement approved. AIDS Patient Care STDS; 2008 Nov; 22(11):918. PubMed ID: 19043841 [No Abstract] [Full Text] [Related]
5. FDA notifications. Pediatric HIV infection guidelines for use of ARTs are revised. AIDS Alert; 2008 Apr; 23(4):46-7. PubMed ID: 19255980 [No Abstract] [Full Text] [Related]
6. Epivir for younger children. Vazquez E Posit Aware; 1999; 10(3):26. PubMed ID: 11366765 [TBL] [Abstract][Full Text] [Related]
7. FDA notifications. FDA approved pediatric efficacy supplement for Retrovir syrup. AIDS Alert; 2008 Nov; 23(11):128. PubMed ID: 19043870 [No Abstract] [Full Text] [Related]
8. ddI: FDA approves once-daily dosing. Food and Drug Administration. James JS AIDS Treat News; 1999 Nov; (No 330):1. PubMed ID: 11367169 [TBL] [Abstract][Full Text] [Related]
9. Review of recent guidelines for antiretroviral treatment of HIV-infected children. Oleske JM Top HIV Med; 2003; 11(6):180-4. PubMed ID: 14724326 [No Abstract] [Full Text] [Related]
10. Pediatric efficacy supplement for Videx EC. AIDS Patient Care STDS; 2008 Nov; 22(11):919. PubMed ID: 19043843 [No Abstract] [Full Text] [Related]
11. Efavirenz: new preparation. An alternative to HIV protease inhibitors. Prescrire Int; 2000 Apr; 9(46):46-9. PubMed ID: 11503786 [TBL] [Abstract][Full Text] [Related]
12. FDA notifications. Reyataz is approved for HIV treatment. AIDS Alert; 2003 Sep; 18(9):119-20. PubMed ID: 14686309 [TBL] [Abstract][Full Text] [Related]
14. HIV antiviral drug guide 1997. Posit Aware; 1997; 8(1):24-33. PubMed ID: 11364095 [TBL] [Abstract][Full Text] [Related]
15. Diminished selection for thymidine-analog mutations associated with the presence of M184V in Ethiopian children infected with HIV subtype C receiving lamivudine-containing therapy. Averbuch D; Schapiro JM; Lanier ER; Gradstein S; Gottesman G; Kedem E; Einhorn M; Grisaru-Soen G; Ofir M; Engelhard D; Grossman Z Pediatr Infect Dis J; 2006 Nov; 25(11):1049-56. PubMed ID: 17072129 [TBL] [Abstract][Full Text] [Related]